Positron Emission Tomography Market Analysis

Based on product type, the market is categorized into partial ring PET scanner and full ring PET scanner. The full ring PET scanner segment led the market with a revenue of USD 1.7 billion in 2024 and is expected to grow at a significant CAGR during the forecast period.

• Full ring PET scanners demonstrate effectiveness across various clinical applications, including oncology, cardiology, neurology, and psychiatry, expanding the patient population that can benefit from PET imaging.
  
• The market growth for full ring PET scanners is further driven by the rising cancer incidence, technological advancements in PET systems, increased demand for personalized medicine, an aging population, and greater awareness of PET imaging capabilities. For instance, the American Cancer Society estimates that there will be nearly 2 million new cancer cases in the U.S. in 2024.
  
• These factors are expected to drive the growth of the overall market during the forecast period.
  

Based on detector type, the positron emission tomography market is segmented into lutetium oxyorthosilicate (LSO), silicon photomultiplier (SiPM), lutetium yttrium orthosilicate (LYSO), digital photon counters (DPC) and other detector types. The lutetium oxyorthosilicate (LSO) detector type segment led the market with a revenue of USD 725.1 million in 2024 and is expected to grow at a significant CAGR during the forecast period.

• LSO PET scanners have become increasingly popular due to their high sensitivity, improved spatial resolution, and ability to acquire images faster than previous-generation PET scanners.
  
• LSO crystals are known for their high sensitivity and fast light decay time, enabling accurate detection of gamma photons and faster imaging processes. This makes LSO PET scanners particularly attractive in oncology, neurology, and cardiology, where detailed and timely diagnostic imaging is crucial.
  
• Additionally, advancements in hybrid imaging systems, such as PET/CT and PET/MRI, have bolstered the adoption of LSO detectors due to their compatibility and enhanced performance in these modalities. Governments and private organizations are also investing in upgrading healthcare infrastructure, especially in developing regions, to incorporate state-of-the-art imaging systems like LSO PET.
  
• Thus, the increasing popularity of LSO detectors will drive segmental growth in the future.
  

Based on end use, the positron emission tomography market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, and other end users. The hospitals segment dominated the market in 2024 and is expected to grow significantly to reach USD 1.4 billion by 2034.

• Hospitals are increasingly adopting PET technology to address the rising prevalence of chronic conditions such as cancer, neurological disorders, and cardiovascular diseases. PET imaging plays a critical role in early detection and personalized treatment planning, aligning with the healthcare industry's shift towards precision medicine.
  
• Its integration with hybrid imaging modalities, like PET/CT and PET/MRI, further enhances diagnostic capabilities, making it an essential tool in modern hospital settings.
  
• Another key factor is the expansion of healthcare infrastructure and government investments in advanced diagnostic technologies, particularly in emerging markets. Hospitals are upgrading their imaging facilities to meet growing patient demand for accurate and non-invasive diagnostic tools. Additionally, advancements in PET technology, such as time-of-flight (TOF) and LSO detectors, have improved image quality, reduced scan times, and enhanced patient comfort, further accelerating hospital adoption.
  

In 2024, the U.S. led the North American positron emission tomography market, generating USD 713.8 million, and is expected to see significant growth during the forecast period.

• The increasing prevalence of cancer and cardiovascular diseases in the U.S. is driving the growth of the market. According to the Centers for Disease Control and Prevention, approximately 680,909 people died from heart disease in the U.S. in 2023. This rising disease burden, combined with an aging population more susceptible to chronic conditions, has increased the demand for accurate diagnostic imaging technologies like PET scanners.
  
• Technological advancements in PET imaging systems, including improved image resolution and reduced scanning times, are contributing to market expansion. The integration of artificial intelligence and machine learning in PET imaging has enhanced diagnostic accuracy and workflow efficiency. Additionally, favorable reimbursement policies for PET procedures and increasing investments in healthcare infrastructure are supporting market growth in the U.S.
  

From 2025 to 2034, France's market is expected to grow significantly.

• France’s robust healthcare infrastructure and favorable reimbursement policies support the growth of the PET market. The country’s commitment to technological advancement in medical imaging, combined with increasing investments in healthcare facilities and research institutions, enhances the adoption of PET systems.
  
• Additionally, the expanding applications of PET imaging beyond oncology, including neurology and cardiology, are contributing to market expansion.
  
• These factors are expected to drive the growth of France’s market during the forecast period.
  

Between 2025 and 2034, the Asia Pacific positron emission tomography market is anticipated to grow significantly.

• The growing aging population, particularly in countries like Japan and China, has led to a higher incidence of chronic diseases that require advanced diagnostic imaging. Additionally, rising healthcare expenditure and improving healthcare infrastructure across developing economies are supporting the adoption of PET scanning technologies in the region.
  
• Moreover, technological advancements in PET imaging systems, coupled with increasing investments in healthcare facilities, are further propelling market growth. Government initiatives to improve cancer diagnosis and treatment facilities, along with the expansion of nuclear medicine in hospitals across countries such as India, South Korea, and Australia, are contributing to market expansion.
  

From 2025 - 2034, South Africa's positron emission tomography market is expected to grow significantly.

• The South African positron emission tomography (PET) market is experiencing significant growth due to increasing collaborations between medical device manufacturers and healthcare providers.
  
• Market expansion is also supported by the growing focus on research and development activities in molecular imaging. The increasing number of clinical trials utilizing PET imaging technology, coupled with rising medical tourism in South Africa, is creating new opportunities for market growth.